Target and Fresh Market Sandwiches
Elevation Foods Recalls Packaged Egg Salad, Tuna Salad, Thai Lobster Salad, and Archer Farms Deviled Egg Sandwiches Because of Possible Health Risk https://t.co/LkYr2POEqP pic.twitter.com/Gen0dK6III
— U.S. FDA Recalls (@FDArecalls) July 22, 2019
Archer Farms deviled egg sandwiches, as well as egg, tuna and Thai lobsters salads sold at Target and Fresh Market, are being recalled. Listeria monocytogenes was found during random testing at the Elevation Foods facility.
Boppy Infant Head and Neck Support Accessories
The Consumer Product Safety Commission has announced a recall of Boppy infant head and neck support accessories, due to a risk of suffocation.https://t.co/ik1q8dfDMh
— Faith Anderson (@MedAlertBlogger) July 24, 2019
Boppy Infant Head and Neck Support Accessories are on the recall list due to the items being overstuffed, which could cause an infant’s head to tilt forward too far causing suffocation. The two styles recalled are Ebony Floral and Heathered Gray.
US Foods Pork and Beef
#Recall: US Foods Recalls Raw Beef and Pork Products Due to Possible Product Contamination https://t.co/hU1gsn6boY
— USDA Food Safety & Inspection Service (@USDAFoodSafety) July 24, 2019
US Foods has recalled over 700 pounds of beef and pork because there is a chance that it’s contaminated with human blood. An employee cut himself during production, potentially contaminating both beef and pork that was going through the production process. The meat was shipped to restaurants in Alabama, Georgia, Mississippi and Tennessee.
Biocell Textured Breast implants
Recall alert: At FDAs request, Allergan is recalling all of its Biocell textured breast implants to protect women from the risk of breast implant associated anaplastic large cell lymphoma. Affected products include both silicone and saline-filled implants https://t.co/EyBP0h4SCd pic.twitter.com/aysTFz5eSw
— U.S. FDA (@US_FDA) July 24, 2019
Allergan has issued a recall of their Biocell textured breast implants after a request from the US Food and Drug Administration.
“Allergan is taking this action as a precaution following notification of recently updated global safety information concerning the uncommon incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) provided by the U.S. Food and Drug Administration (FDA).”
-Allergan press release
Copyright 2019, UnitedVoice.com
